Renin Angiotensin System, Vasopressin, and Kinins Flashcards
Candesartan
ARBs
AT1 Receptor Antagonist (blocker)
Non-Peptide
Primarily used in HTN, HF
Lack some side effects seen with ACE inhibitors
Higher affinity for AT1 than AT2, Mas receptors
Don’t effect kininase II
Blood pressure lowering due to residual AT2 receptor activation
- Via increased production of Ang(1-7)
Blockade of AT1 receptors results in loss of AII feedback inhibiton of renin release from kidney
- PROMOTE renin release
- Leads to more AI and AII production
- Made into Ang(1-7) via ACEII
Adverse Effect:
- Hypotension
- Hyperkalemia
- Pts with renal insufficiency: acute renal failure
Contraindicated in pregnant and nursing mothers
irbesartan
ARBs
AT1 Receptor Antagonist (blocker)
Non-Peptide
Primarily used in HTN, HF
Lack some side effects seen with ACE inhibitors
Higher affinity for AT1 than AT2, Mas receptors
Don’t effect kininase II
Blood pressure lowering due to residual AT2 receptor activation
- Via increased production of Ang(1-7)
Blockade of AT1 receptors results in loss of AII feedback inhibiton of renin release from kidney
- PROMOTE renin release
- Leads to more AI and AII production
- Made into Ang(1-7) via ACEII
Adverse Effect:
- Hypotension
- Hyperkalemia
- Pts with renal insufficiency: acute renal failure
Contraindicated in pregnant and nursing mothers
losartan
ARBs
AT1 Receptor Antagonist (blocker)
Non-Peptide
Primarily used in HTN, HF
Lack some side effects seen with ACE inhibitors
Higher affinity for AT1 than AT2, Mas receptors
Don’t effect kininase II
Blood pressure lowering due to residual AT2 receptor activation
- Via increased production of Ang(1-7)
Blockade of AT1 receptors results in loss of AII feedback inhibiton of renin release from kidney
- PROMOTE renin release
- Leads to more AI and AII production
- Made into Ang(1-7) via ACEII
Adverse Effect:
- Hypotension
- Hyperkalemia
- Pts with renal insufficiency: acute renal failure
Contraindicated in pregnant and nursing mothers
valsartan
ARBs
AT1 Receptor Antagonist (blocker)
Non-Peptide
Primarily used in HTN, HF
Lack some side effects seen with ACE inhibitors
Higher affinity for AT1 than AT2, Mas receptors
Don’t effect kininase II
Blood pressure lowering due to residual AT2 receptor activation
- Via increased production of Ang(1-7)
Blockade of AT1 receptors results in loss of AII feedback inhibiton of renin release from kidney
- PROMOTE renin release
- Leads to more AI and AII production
- Made into Ang(1-7) via ACEII
Adverse Effect:
- Hypotension
- Hyperkalemia
- Pts with renal insufficiency: acute renal failure
Contraindicated in pregnant and nursing mothers
captopril
ACE inhibitor
Antihypertensive Primary Use
Left ventricular systolic dysfunction: reduces mortality
Myocardial Infarcation: reduces mortality
Heart failure: reduces mortality
Adverse Effects: - Hypotension - Renal failure in renal insufficient patients - Hyperkalemia Additionally: - Dry cough (due to bradykinin) - Angioedema
Blood pressure effects via: Ang-(1-7) production
Results due to shunt of AI to make Ang(1-7)
enalapril
ACE inhibitor
Antihypertensive Primary Use
Left ventricular systolic dysfunction: reduces mortality
Myocardial Infarcation: reduces mortality
Heart failure: reduces mortality
Adverse Effects: - Hypotension - Renal failure in renal insufficient patients - Hyperkalemia Additionally: - Dry cough (due to bradykinin) - Angioedema
Blood pressure effects via: Ang-(1-7) production
Results due to shunt of AI to make Ang(1-7)
lisinopril
ACE inhibitor
Antihypertensive Primary Use
Left ventricular systolic dysfunction: reduces mortality
Myocardial Infarcation: reduces mortality
Heart failure: reduces mortality
Adverse Effects: - Hypotension - Renal failure in renal insufficient patients - Hyperkalemia Additionally: - Dry cough (due to bradykinin) - Angioedema
Blood pressure effects via: Ang-(1-7) production
Results due to shunt of AI to make Ang(1-7)
conivaptan
Vasopressin Receptor Antagonist
Non-peptide vasopressin receptor antagonist
V1/V2 receptor
Approved for treatment of hyponatremia caused by SIADH (syndrome of inappropriate antidiuretic hormone)
- Water retention is mediated by secretion of vasopressin
- Administered by IV to hospitalized patients to increase serum sodium conc.
tolvaptan
Vasopressin Receptor Antagonist
Selective V2 receptor antagonist
Orally adminstered for treatment of hypervolemic and euvolemic hyponatremia that is resistant to to fluid restriction
- HF
- Cirrhosis
- SIADH
aliskiren
Renin Inhibitor
Non-peptide based renin inhibitor that is approved for treatment of essential hypertension
Adverse effect: - Hypotension - Hyperkalemia - Renal Failure in renal patients - Dry cough - angioedema and GI/allergic symptoms
Has effect in patients that are Na-depleted